Brief: Cereno Scientific: Patent Grant in US
31/10/2018 15:39
Oct 31 (Reuters) - Cereno Scientific AB CRNOSb.TE :
* CERENO SCIENTIFIC'S PATENT IS GRANTED IN US FOR USE OF DRUG CANDIDATE CS1
* US PATENT WILL BE VALID THROUGH 2035
* PATENT CAN BE EXTENDED FOR ADDITIONAL FIVE YEAR MAXIMUM
Source text for Eikon: ID:nWkrJ4dJ2
Further company coverage: CRNOSb.TE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Cereno Scientific AB
See all newsBrief: Cereno Scientific Expects Up To 15 Activated Sites By 2026 In Epimode Trial
Brief: Cereno Scientific Reports Positive Results From Study
Brief: Cereno Scientific Q2 Net Sales Sek 0
Sweden's Cereno Scientific Q2 net loss widens, hurt by clinical development costs
Brief: Cereno Scientific Q2 Loss After Financial Items SEK 30.5 Mln